Advertisement
Advertisement
GSK
GSK plc - ADR
53.34
USDSponsored
+0.88
+1.68%
Feb 03, 15:59 UTC -5
Closed
Pre-Market
55.22
+1.88
+3.52%
GSK Earnings Reports
Positive Surprise Ratio
GSK beat 32 of 39 last estimates.
82%
Next Report
Today BMO
Date of Next Report
Feb 04, 2026
Estimate for Q4 25 (Revenue/ EPS)
$8.73B
/$0.23
Implied change from Q3 25 (Revenue/ EPS)
+2.10%
/-58.18%
Implied change from Q4 24 (Revenue/ EPS)
+7.51%
/--
GSK plc - ADR earnings per share and revenue
On Oct 29, 2025, GSK reported earnings of 0.55 USD per share (EPS) for Q3 25, beating the estimate of 0.48 USD, resulting in a 12.80% surprise. Revenue reached 8.55 billion, compared to an expected 8.57 billion, with a -0.28% difference. The market reacted with a +5.10% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 9 analysts forecast an EPS of 0.23 USD, with revenue projected to reach 8.73 billion USD, implying an decrease of -58.18% EPS, and increase of 2.10% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Amgen Inc
Report Date
Feb 03, 2026 For Q4 25
Estimate
$4.82
Actual
$5.29
Surprise
+9.56%
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.82
Actual
$11.44
Surprise
+5.65%
Twist Bioscience Corporation Common Stock
Report Date
Feb 02, 2026 For Q1 26
Estimate
-$0.43
Actual
-$0.50
Surprise
-14.00%
Mesoblast Limited - ADR
Report Date
Jan 29, 2026 For Q1 26
Estimate
-$0.06
Actual
-$0.07
Surprise
-5.90%
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
AYTU BioPharma, Inc. Common Stock
Report Date
Feb 03, 2026 For Q2 26
Estimate
-$0.61
Actual
-$1.05
Surprise
-71.57%
FAQ
What were GSK plc - ADR's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, GSK plc - ADR reported EPS of $0.55, beating estimates by 12.8%, and revenue of $8.55B, -0.28% below expectations.
How did the market react to GSK plc - ADR's Q3 2025 earnings?
The stock price moved up 5.1%, changed from $43.70 before the earnings release to $45.93 the day after.
When is GSK plc - ADR expected to report next?
The next earning report is scheduled for Feb 04, 2026.
What are the forecasts for GSK plc - ADR's next earnings report?
Based on 9
analysts, GSK plc - ADR is expected to report EPS of $0.23 and revenue of $8.73B for Q4 2025.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement